Gudrun Schappacher-Tilp

Title: Gudrun Schappacher-Tilp: Innovator in Oxygen Dosing Technology

Introduction

Gudrun Schappacher-Tilp is a notable inventor based in Waltham, MA (US). She has made significant contributions to the field of medical technology, particularly in the area of oxygen dosing. Her innovative work has the potential to enhance the quality of life for individuals requiring precise oxygen management.

Latest Patents

Gudrun holds a patent for a system and method for attaining desired oxygen dosing based on erythropoiesis modeling. This computing system is designed to determine a systematic training strategy for users. It includes a user device that utilizes sensors to monitor partial pressure of oxygen (PO2) levels over time. The device provides historical PO2 data to a personalized erythropoiesis model generation platform. This platform analyzes individualized user data, including previous hematocrit and hemoglobin measurements, to create a tailored erythropoiesis model. The model predicts hematocrit and hemoglobin levels, allowing the system to perform actions based on these predictions.

Career Highlights

Throughout her career, Gudrun has worked with prominent companies in the medical field, including Fresenius Medical Care Holdings, Inc. and Fresenius Medical Care Deutschland GmbH. Her experience in these organizations has contributed to her expertise in developing innovative medical solutions.

Collaborations

Gudrun has collaborated with notable professionals in her field, including Peter Kotanko and Ulrike Kotanko. These partnerships have likely enriched her research and development efforts.

Conclusion

Gudrun Schappacher-Tilp is a pioneering inventor whose work in oxygen dosing technology exemplifies innovation in medical science. Her contributions are poised to make a significant impact on patient care and treatment strategies.